Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Victor Mudhune(Kenya Medical Research Institute), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Breno Santos(Hospital Nossa Senhora da Conceição), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Marybeth McCauley(Family Health International 360), Ravindre Panchia(Chris Hani Baragwanath Hospital), Ian Sanne(University of the Witwatersrand), Craig W. Hendrix(Unknown), Joseph Makhema(Norwegian Womens Public Health Association), Namandjé N. Bumpus(Johns Hopkins University), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Susan H. Eshleman(Johns Hopkins University), Lei Wang(Xihua University), Ying Chen(Shandong University of Traditional Chinese Medicine), Nagalingeswaran Kumarasamy(YR Gaitonde Centre for AIDS Research and Education), San San Ou, James Hakim(University of Zimbabwe), Mina C. Hosseinipour, Teresa L. Parsons(Johns Hopkins University), Jessica M. Fogel(Johns Hopkins University)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k